Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Phenotype plasticity as enabler of melanoma progression and therapy resistance
Imanol Arozarena, Claudia Wellbrock
Nature reviews. Cancer (2019) Vol. 19, Iss. 7, pp. 377-391
Open Access | Times Cited: 325

Showing 1-25 of 325 citing articles:

PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer
Antonino Glaviano, Aaron Song Chuan Foo, Hiu Yan Lam, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 704
The great escape: tumour cell plasticity in resistance to targeted therapy
Soufiane Boumahdi, Frédéric J. de Sauvage
Nature Reviews Drug Discovery (2019) Vol. 19, Iss. 1, pp. 39-56
Closed Access | Times Cited: 596
Single-cell analysis reveals new evolutionary complexity in uveal melanoma
Michael Durante, Daniel A. Rodriguez, Stefan Kurtenbach, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 368
From bulk, single-cell to spatial RNA sequencing
Xinmin Li, Cun‐Yu Wang
International Journal of Oral Science (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 306
Emergence of a High-Plasticity Cell State during Lung Cancer Evolution
Nemanja D. Marjanovic, Matan Hofree, Jason E. Chan, et al.
Cancer Cell (2020) Vol. 38, Iss. 2, pp. 229-246.e13
Open Access | Times Cited: 298
Mechanism of RNA modification N6-methyladenosine in human cancer
Zijian Zhou, Jiancheng Lv, Hao Yu, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 224
Signal pathways of melanoma and targeted therapy
Weinan Guo, Huina Wang, Chunying Li
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 224
Therapy resistance: opportunities created by adaptive responses to targeted therapies in cancer
Marilyne Labrie, Joan S. Brugge, Gordon B. Mills, et al.
Nature reviews. Cancer (2022) Vol. 22, Iss. 6, pp. 323-339
Open Access | Times Cited: 223
Emerging role of tumor cell plasticity in modifying therapeutic response
Siyuan Qin, Jingwen Jiang, Yi Lü, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 192
The plasticity of mRNA translation during cancer progression and therapy resistance
Lucilla Fabbri, Alina Chakraborty, Caroline Robert, et al.
Nature reviews. Cancer (2021) Vol. 21, Iss. 9, pp. 558-577
Closed Access | Times Cited: 175
Tumor Functional Heterogeneity Unraveled by scRNA-seq Technologies
Laura González-Silva, Laura Quevedo, Ignacio Varela
Trends in cancer (2020) Vol. 6, Iss. 1, pp. 13-19
Open Access | Times Cited: 169
Melanoma models for the next generation of therapies
E. Elizabeth Patton, Kristen L. Mueller, David J. Adams, et al.
Cancer Cell (2021) Vol. 39, Iss. 5, pp. 610-631
Open Access | Times Cited: 158
A cellular hierarchy in melanoma uncouples growth and metastasis
Panagiotis Karras, Ignacio Bordeu, Joanna Poźniak, et al.
Nature (2022) Vol. 610, Iss. 7930, pp. 190-198
Open Access | Times Cited: 152
Evolutionary predictability of genetic versus nongenetic resistance to anticancer drugs in melanoma
Oskar Marín-Béjar, Aljosja Rogiers, Michael Dewaele, et al.
Cancer Cell (2021) Vol. 39, Iss. 8, pp. 1135-1149.e8
Open Access | Times Cited: 109
The journey from melanocytes to melanoma
Patricia P. Centeno, Valeria Pavet, Richard Marais
Nature reviews. Cancer (2023) Vol. 23, Iss. 6, pp. 372-390
Closed Access | Times Cited: 82
Single-cell sequencing of ascites fluid illustrates heterogeneity and therapy-induced evolution during gastric cancer peritoneal metastasis
Xuanzhang Huang, Min-Jiao Pang, Jiayi Li, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 45
Exosome camouflaged coordination-assembled Iridium(III) photosensitizers for apoptosis-autophagy-ferroptosis induced combination therapy against melanoma
Tao Feng, Zixin Tang, Johannes Karges, et al.
Biomaterials (2023) Vol. 301, pp. 122212-122212
Closed Access | Times Cited: 45
BRAF — a tumour-agnostic drug target with lineage-specific dependencies
Aphrothiti J. Hanrahan, Ziyu Chen, Neal Rosen, et al.
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 3, pp. 224-247
Closed Access | Times Cited: 39
EMT-Inducing Transcription Factors, Drivers of Melanoma Phenotype Switching, and Resistance to Treatment
Yaqi Tang, Simon Durand, Stéphane Dalle, et al.
Cancers (2020) Vol. 12, Iss. 8, pp. 2154-2154
Open Access | Times Cited: 75
ST3GAL1 is a target of the SOX2-GLI1 transcriptional complex and promotes melanoma metastasis through AXL
Silvia Pietrobono, Giulia Anichini, Cesare Sala, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 71
Mechanisms of Resistance to PI3K Inhibitors in Cancer: Adaptive Responses, Drug Tolerance and Cellular Plasticity
Sarah Christine Elisabeth Wright, Natali Vasilevski, Violeta Serra, et al.
Cancers (2021) Vol. 13, Iss. 7, pp. 1538-1538
Open Access | Times Cited: 68
MITF reprograms the extracellular matrix and focal adhesion in melanoma
Ramile Dilshat, Valerie Fock, Colin Kenny, et al.
eLife (2021) Vol. 10
Open Access | Times Cited: 61
ZEB1 transcription factor promotes immune escape in melanoma
Maud Plaschka, Valentin Benboubker, Maxime Grimont, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 3, pp. e003484-e003484
Open Access | Times Cited: 57
Mechanisms of resistance to immune checkpoint inhibitors in melanoma: What we have to overcome?
Dimitrios C. Ziogas, Charalampos Theocharopoulos, Tilemachos Koutouratsas, et al.
Cancer Treatment Reviews (2022) Vol. 113, pp. 102499-102499
Closed Access | Times Cited: 54
Mechanisms of tumor resistance to immune checkpoint blockade and combination strategies to overcome resistance
Xiaoting Zhou, Yanghong Ni, Xiao Liang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 52
Page 1 - Next Page

Scroll to top